India Cord Stem Cell Banking Market - Industry Trends and Forecast to 2026

  • Medical Devices
  • Published Report
  • Aug 2019
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 9
  • No of Figures: 18

India Cord Stem Cell Banking Market By Source (Umbilical Cord, Placenta, Amniotic Sac, Amniotic Fluid), Application (Blood Disorders/Bone Marrow Failure, Cancers, Neurologic Disorders, Genetic Disorder, Metabolic Disorders, Immune Disorders, Others), Mode of Treatment (Autologous, Allogeneic), Service Type (Sample Preservation and Storage, Sample Processing, Sample Analysis, Sample Collection and Transportation), Cord Blood Banking (Private Cord Blood Banks, Public Cord Blood Banks) - Industry Trends and Forecast to 2026

Cord blood banking involves storage of cord blood extracted from umbilical cord and placenta after birth. This cord blood can be used in the treatment of number of diseases such as cancers, blood disorders, metabolic disorders and many others. Cord blood stem cell is booming in medicine industry as regenerative medicine because of its importance in treating around 80 diseases.

Cord blood banks are of two types available in India such as, public or private banks. Private Banks are also called as family bank and they stores cord blood for autologous use. These banks charge yearly fees for storing cord blood of an individual. The cord blood stored in private banks is only for the donor people not for universal people. In public banks, it costs parents nothing to donate (no fees required for collection, processing and storage) and can be accessed universally by the people as per their need and hence it is also called as non-profit organization. For instance, Jeevan, a public cord blood bank which collects, process and stores cord blood but does not charge the donor which ultimately shows that the organization is not earning any profit.

India cord stem cell banking market is projected to register a healthy CAGR of 12.6% in the forecast period of 2019 to 2026.

Segmentation: India Cord Stem Cell Banking Market

India cord stem cell banking market is segmented into notable five segments and which are source, application, mode of treatment, service type and cord blood banking.

  • On the basis of source, the market is segmented into umbilical cord, placenta, amniotic sac and amniotic fluid.

    • In August 2017, Lifecell launched collection kit, an improved version of umbilical cord-stem cell. The kit is made up of stainless steel, which provides maximum protection to the sample and maintains low temperature to keep efficiency of sample. The kit is launched for the better transport of the stem cell right from the hospitals to the cryo-banks. This product launched is the novel value addition to the company’s’ services for better sample handling.

  • On the basis of application, the market is segmented into blood disorders/bone marrow failure, cancers, neurologic disorders, genetic disorder, metabolic disorders, immune disorders and others.

    • In February 2013, Reliance plans to expand triple stem cell units, almost three times capacity of its stem-cell enriched cord blood repository to close to 10,000 cell units. The company aim to scale it up to 30,000 cell units over a period of time.

  • On the basis of mode of treatment, the market is segmented into allogeneic and autologous.

    • In July 2014, Cordlife Group announced collaboration with China Cord Blood Corporation to help patients over Hong Kong, Singapore, PRC, Indonesia, India and Philippines to find out suitable match of cord blood unit for cell therapies.

  • On the basis of service type, the market is segmented into sample collection and transportation, sample processing, sample analysis and sample preservation and storage.

    • In November 2016, Mycord introduced a new concept, revolutionary private umbilical cord blood banking. All cord blood units are stored in this bank as part of private banking and this banking allows a person to access only their own cord blood for the treatment purpose. This banking helped the market in order to increase revenue because private banks charge fees for each service required in cord blood banking.

  • On the basis of cord blood banking, the market is segmented into private cord blood banks and public cord blood banks.

    • In March 2017, Lifecell launched Baby Cord Share. It is a community stem cell banking that fulfils the need of people and contains large inventory of stem cells in India. Baby Cord Share provides unique benefits of both private as well as public banks. This service was launched to raise the chances of finding a matching donor.

Competitive Analysis: India Cord Stem Cell Banking Market

Some of the major players operating in this market are Cordlife Group Limited, LifeCell, Mycord (CelluGen Biotech Pvt. Ltd.), Reliance Life Sciences, Cryoviva India, Global Cord Blood Corporation, Cryo-Cell International, Inc., REGROW BIOSCIENCES PVT LTD, ReeLabs Pvt. Ltd. and others.

Developments:

  • In November 2016, Cordlife Group accepted accreditation from College of American Pathologists for its majority owned subsidiaries, present in Hong Kong Screening Centre Limited and Cordlife Sciences (India) Pvt. Ltd.
  • In February 2013, Reliance plans to expand triple stem cell units, almost three times capacity of its stem-cell enriched cord blood repository to close to 10,000 cell units. The company aim to scale it up to 30,000 cell units over a period of time.

Research Methodology: India Cord Stem Cell Banking Market

Primary Respondents: Key Industry Participants, Subject-Matter Experts (SMEs), C-level Executives of Key Market Players, Market Intelligence Managers, National Sales Managers and Industry Consultants.


SKU-

TABLE 1 TABLE: THE PRIVATE BLOOD BANKS IN INDIA CHARGE FEES FOR PRESERVING CORD BLOOD STEM CELLS AS SHOWN.

TABLE 2 INDIA CORD STEM CELL BANKING MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 3 INDIA UMBILICAL CORD IN CORD STEM CELL BANKING MARKET, BY SOURCE, 2017-2026 (USD MILLION)

TABLE 4 INDIA CORD STEM CELL BANKING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 5 INDIA CANCERS IN CORD STEM CELL BANKING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 6 INDIA METABOLIC DISORDERS IN CORD STEM CELL BANKING MARKET, BY APPLICATION, 2017-2026 (USD MILLION)

TABLE 7 INDIA CORD STEM CELL BANKING MARKET, BY MODE OF TREATMENT, 2017-2026 (USD MILLION)

TABLE 8 INDIA CORD STEM CELL BANKING MARKET, BY SERVICE TYPE, 2017-2026 (USD MILLION)

TABLE 9 INDIA CORD STEM CELL BANKING MARKET, BY CORD BLOOD BANKING, 2017-2026 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE